January 21, 2021ORGOVYX (relugolix), the First FDA-Approved Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer, Available at Biologics by McKesson
December 28, 2020McKesson Corporation Announces Third Quarter Fiscal 2021 Earnings Release Date and Participation in January Conferences